ENROLLED
2023 Regular Session
HOUSE CONCURRENT RESOL UTION NO. 120
BY REPRESENTATIVES DAVIS, BISHOP, BROWN, BUTLER, COX, FISHER,
HILFERTY, HORTON, HUGHES, ILLG, JORDAN, LAFLEUR, LARVADAIN,
MCFARLAND, NEWELL, PIERRE, PRESSLY, THOMPSON, AND WILLARD
A CONCURRENT RESOL UTION
To create a subcommittee to be comprised of members of the House Committee on Health
and Welfare, the Senate Committee on Health and Welfare, the House Committee
on Insurance, and the Senate Committee on Insurance to study Louisiana's efforts to
prevent, treat, and cure nonmelanoma skin cancer, to develop recommendations for
continued improvement in preventive and treatment practices as it relates to
nonmelanoma skin cancer, and to report an initial and final findings.
WHEREAS, Louisiana has the eighth highest occurrence of nonmelanoma skin
cancer in the United States; and
WHEREAS, on May 15, 2022, Governor John Bel Edwards issued a proclamation
urging Louisiana citizens to learn about risk factors, preventative strategies, and available
treatment options, including but not limited to Mohs or micrographically oriented
histographic surgery, topical chemical treatments, and image-guided superficial
radiotherapy; and
WHEREAS, public policy should protect and embolden the unique relationship
between a patient and his physician in order to promote the ability to prevent, treat, and cure
occurrences of nonmelanoma skin cancer in a timely and effective manner; and
WHEREAS, healthcare providers are best situated to work with their patients to
determine the most effective and efficient treatment options, including but not limited to
reaching a determination of which treatment options are medically necessary; and
WHEREAS, medical research shows that certain preventive and treatment options
may be more effective and efficient than other types of treatment based on the diagnosis and
severity of the patient's nonmelanoma skin cancer; and
Page 1 of 3 HCR NO. 120 ENROLLED
WHEREAS, a result of research, development, and innovation, patients and
healthcare providers have several options to consider to treat nonmelanoma skin cancer, such
as image-guided radiotherapy and topical chemical treatments, which may be more effective,
less invasive, result in fewer side effects, and require less recovery; and
WHEREAS, early detection and effective treatment options are shown to
substantially reduce the mortality rate of nonmelanoma skin cancer, the recurrence of the
disease, the physical and health burden of a patient, and the overall costs associated with
treatment; and
WHEREAS, this subcommittee builds on the foundation of the proclaimed
"Nonmelanoma Skin Cancer Awareness Week" on May 15 to May 21, 2022, by providing
public officials an avenue to identify policy opportunities to assist, support, and improve
Louisiana's ongoing battle against this deadly disease.
THEREFORE, BE IT RESOLVED that the Legislature of Louisiana does hereby
create a subcommittee of the House Committee on Health and Welfare; the Senate
Committee on Health and Welfare; the House Committee on Insurance; and the Senate
Committee on Insurance to study the practices and policies related to educating, preventing,
and treating nonmelanoma skin cancer for Louisiana residents.
BE IT FURTHER RESOLVED that the subcommittee shall be composed of twelve
members from the following committees:
(1) Three members from the House Committee on Health and Welfare.
(2) Three members from the Senate Committee on Health and Welfare.
(3) Three members from the House Committee on Insurance.
(4) Three members from the Senate Committee on Insurance.
BE IT FURTHER RESOLVED that the speaker of the House of Representatives
shall appoint members from the House committees on health and welfare and insurance, and
the president of the Senate shall appoint members from the Senate committees on health and
welfare and insurance.
BE IT FURTHER RESOLVED that the subcommittee may call upon the staffs of
any department, agency, or official of the state for data and assistance and all such
departments, agencies, and officials shall cooperate with the subcommittee, and the
subcommittee may request and utilize the assistance of any and all public and private
Page 2 of 3 HCR NO. 120 ENROLLED
sources, including but not limited to residents, elected officials, medical experts, scientists,
and nongovernmental organizations.
BE IT FURTHER RESOLVED that the subcommittee shall study all of the
following:
(1) Existing awareness, detection, and treatment programs and procedures available
to Louisiana residents relative to nonmelanoma skin cancer and, if applicable, the efficacy
of such programs and procedures.
(2) Accessibility of treatment options, including coverage by insurance providers,
for available programs and procedures related to the prevention and treatment of
nonmelanoma skin cancer occurrences.
(3) References and case studies, if any, regarding practices and procedures in other
states relative to the prevention and treatment of nonmelanoma skin cancer.
(4) Public and private initiatives, programs, and efforts, if any, to raise awareness,
encourage prevention, and provide treatment related to nonmelanoma skin cancer.
(5) Legislation or regulatory policy, if any, to improve awareness, detection, and
access to treatment options related to nonmelanoma skin cancer.
(6) Economic analysis related to prevention, detection, and treatment of
nonmelanoma skin cancer for Louisiana residents.
(7) Public health impact analysis of nonmelanoma skin cancer as it pertains to age,
gender, ethnicity, race, and socioeconomic status and the disparity, if any, of access and
efficacy of prevention, detection, and treatment options within such demographic subgroups.
BE IT FURTHER RESOLVED that the subcommittee shall make a report of findings
and recommendations to the Legislature of Louisiana by December 1, 2024.
BE IT FURTHER RESOLVED that the subcommittee shall terminate on December
1, 2024.
SPEAKER OF THE HOUSE OF REPRESENTATIVES
PRESIDENT OF THE SENATE
Page 3 of 3